Nonsegmental Vitiligo
📧 Sign up to get email alerts when something new happens for Nonsegmental Vitiligo.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2) [Phase 3]
Phase 3 STOP-V2 trial evaluating povorcitinib in nonsegmental vitiligo is currently active and not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo [Phase 3]
Pfizer completed a 52-week Phase 3 study evaluating oral ritlecitinib in adults and adolescents with nonsegmental vitiligo (active and stabl…
-
CLINICAL_TRIALS trial_result · 2023-07-05Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo [Phase 2]
Phase 2 study evaluating INCB054707 for nonsegmental vitiligo has completed with results posted.